Tag:
ARX424
Latest Headlines
Latest Headlines
Ambrx, Merck KGaA ink MS development deal
San Diego-based Ambrx has garnered an undisclosed upfront payment from Merck KGaA in a deal to co-develop ARX424, a new therapy for multiple sclerosis. Ambrx also gets an undisclosed equity
